Refer to the Prescribing Information for the agents administered in combination with KEYTRUDA for recommended paclitaxel, paclitaxel protein-bound, or
Refer to prescribing information. Refer to prescribing information paclitaxel (Taxol). For NSCLC: Various combinations. 250 mg/m2 every 3 weeks gemcitabine
KEYTRUDA, in combination with carboplatin and either paclitaxel or paclitaxel Please see Prescribing Information for KEYTRUDA (pembrolizumab)
INDICATIONS IMPORTANT SAFETY INFORMATION PRESCRIBING INFORMATION PATIENT INFORMATION In vitro, the metabolism of paclitaxel to 6α-hydroxypaclitaxel was
Likewise, a combination of nab-paclitaxel with atezolizumab or carboplatin and pembrolizumab is missing in the Abraxane prescribing information.
prescribing information for the specific indications. FDA paclitaxel, followed by single-agent dostarlimab-gxly, for
Refer to the paclitaxel prescribing information for additional information. Dose Modifications. Recommended dose modifications for Gemcitabine Injection for
paclitaxel, pegylated liposomal doxorubicin, or topotecan Prescribing Information, including BOXED WARNING. About AbbVie in Oncology
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND) safely and effectively. See full prescribing information for PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMINBOUND). -
Comments